Munafa Stock Market Course + Intraday & FNO calls 
MA NEWS why is Mastercard Incorporated price falling or rising
MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising
MA Mastercard Incorporated is falling or rising technical reasons
Technical analysis forecast of Mastercard Incorporated Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Mastercard Incorporated MA at this time. Stock is rising and might rise more.
It appears as if Mastercard Incorporated MA gave a large move recently.
Stock of Mastercard Incorporated (MA) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
Although my analysis for Mastercard Incorporated is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 594.3, for a target of 581.5 or 570.79
MA Mastercard Incorporated is falling or rising NEWS fundamental reasons
Sun Pharma Share Price Highlights: Sun Pharma Stock Price History - NEWS as on 2026-08-26 indiatimes.com
Quick Wrap: Nifty Pharma Index gains 0.85% Powered by Capital Market - Live News - NEWS as on 2026-08-25 business-standard.com
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observations Aurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducted this routine inspection from August 17-21, 2026. Four procedural observations were noted during the Seymour, USA fa - NEWS as on 2026-08-24 indiatimes.com
3 Top-Ranked Stocks to Buy After Strong Earnings Beats: KEYS, BMA & ZIM Keysight Technologies (KEYS), Macro Bank (BMA), and ZIM Integrated Shipping Services (ZIM) are three top-rated stocks to consider after crushing earnings expectations last week. - NEWS as on 2026-08-24 nasdaq.com
Medical devices industry needs to focus more on local value addition: Pharma Secy The medical devices sector must increase local value addition and component manufacturing. Government officials are open to industry suggestions for PLI scheme beneficiaries. Many companies invested but could not claim incentives for various reasons. The g - NEWS as on 2026-08-21 indiatimes.com
Mankind Pharma signs in-licensing deal for Insulin Aspart and Insulin Degludec Mankind Pharma has entered into an exclusive in-licensing and marketing agreement with Chongqing Chenan Biopharmaceutical Co., China, for the commercialisation of two insulin analogues, Insulin Degludec and Insulin Degludec + Aspart Combination, in India. - NEWS as on 2026-08-21 business-standard.com
Mankind Pharma signs China pact to market insulin analogues in India Firm eyes more partnerships with Chinese pharmaceutical companies to expand its in-licensed drug pipeline as it seeks a larger presence in injectable diabetes therapies - NEWS as on 2026-08-20 business-standard.com
Market wrap: HCL Tech, Sun Pharma, Power Grid, Bajaj Finance top gainers and losers on Nifty and Sensex on Wednesday Indian equities extended losses for a seventh session, with Nifty falling 0.32% and Sensex 0.42% ahead of US FOMC minutes. IT stocks gained, but broader markets weakened. Analysts flagged 24,000 as crucial Nifty support amid persistent sell-on-rallies sent - NEWS as on 2026-08-19 indiatimes.com
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally - NEWS as on 2026-08-19 marketwatch.com
BSE hits 4-month low after Jefferies, Nuvama downgrade stock on CAS risks Brokerages flag pressure from the closing auction session, weaker derivatives volumes and RBI bank guarantee norms, with BSE shares down nearly 9.3% in August so far - NEWS as on 2026-08-18 business-standard.com
Scholar Rock Eyes Sept. 30 FDA Decision for SMA Drug Apitegromab 3 Beaten-Down Stocks With Rebound Potential This Earnings SeasonScholar Rock (NASDAQ:SRRK) CEO David Hallal said the company is preparing for a September 30 FDA decision date for apitegromab, its investigational treatment for spinal muscular atrophy, or SM - NEWS as on 2026-08-17 nasdaq.com
Alluri Sitarama Raju airport welcomes 1st flight with water salute; passengers praise infrastructure - NEWS as on 2026-08-17 indiatimes.com
3 Large-Cap Stocks to Watch as Pharma Recovery Takes Hold In the Large-Cap Pharmaceuticals industry, LLY, J&J and BAYRY are worth watching as the industry shows a strong recovery. - NEWS as on 2026-08-14 nasdaq.com
More announcements and NEWS
MA Mastercard Incorporated current price & indicator signals
Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 25 Tue Aug 2026 | 599.37 | 595.35 to 601.23 | -0.08% | 1.27 times |
| 24 Mon Aug 2026 | 599.86 | 584.22 to 599.99 | 3.31% | 1.18 times |
| 21 Fri Aug 2026 | 580.63 | 573.04 to 582.28 | 1.18% | 0.83 times |
| 20 Thu Aug 2026 | 573.85 | 571.80 to 579.61 | 0.05% | 0.99 times |
| 19 Wed Aug 2026 | 573.54 | 570.33 to 582.93 | -0.13% | 0.6 times |
| 18 Tue Aug 2026 | 574.31 | 563.18 to 578.50 | 2.14% | 1.48 times |
| 17 Mon Aug 2026 | 562.26 | 561.26 to 569.27 | -1.23% | 1.14 times |
| 14 Fri Aug 2026 | 569.29 | 564.44 to 570.67 | 0.4% | 0.93 times |
| 13 Thu Aug 2026 | 567.04 | 557.70 to 568.28 | 1.31% | 0.75 times |
| 12 Wed Aug 2026 | 559.73 | 556.06 to 563.55 | -0.3% | 1.17 times |
| 11 Tue Aug 2026 | 561.44 | 560.00 to 567.63 | -0.31% | 0.93 times |
| 10 Mon Aug 2026 | 563.17 | 559.36 to 566.77 | 0.04% | 1 times |
Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
